Curis
CRIS
#10301
Rank
C$15.24 M
Marketcap
C$1.18
Share price
1.15%
Change (1 day)
-76.30%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.09. In 2024 the company made an earnings per share (EPS) of C-$9.75 an increase over its 2023 EPS that were of C-$12.53.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-46.68%
2024C-$9.75-22.15%
2023C-$12.53-26.17%
2022C-$16.9622.3%
2021C-$13.87-25.37%
2020C-$18.59-30.93%
2019C-$26.91-2.02%
2018C-$27.47
2016C-$62.42-10%
2015C-$69.36138.1%
2014C-$29.1340%
2013C-$20.81-25%
2012C-$27.7466.67%
2011C-$16.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
C$3.30-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.96-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$4.69-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.39-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.12-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.59 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA